Detalles de la búsqueda
1.
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study.
Cardiovasc Diabetol
; 23(1): 82, 2024 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402400
2.
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort.
Am J Respir Crit Care Med
; 207(5): 587-593, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094461
3.
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial.
Am J Prev Cardiol
; 18: 100681, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800835
4.
Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.
Diabetes Care
; 47(5): 835-843, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484336
5.
The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants.
Diabetes Care
; 46(11): 1941-1948, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639669
6.
Relationship Between Time-Varying Achieved High-Density Lipoprotein Cholesterol and Risk of Coronary Events Depends on Haptoglobin Phenotype Within the ACCORD Lipid Study.
J Am Heart Assoc
; 12(19): e030288, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776200
7.
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.
Diabetes Care
; 45(1): 241-250, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34785535
Resultados
1 -
7
de 7
1
Próxima >
>>